The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study
This study is currently recruiting participants.
Verified July 2013 by University of Utah
University of Utah
Shire Human Genetic Therapies, Inc.
Information provided by (Responsible Party):
Ashok K. Tuteja, University of Utah
First received: June 24, 2011
Last updated: July 3, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||December 2014|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|